British National Formulary 72 2.3.3
You'll be able to download in 5 seconds.
ABOUT British National Formulary 72
This Medical Association and Royal Pharmaceutical Society of Great Britain app-book, British National Formulary (BNF) 72, is developed by Medhand Mobile Libraries. Improve your performance with relevant, valid material which is accessed quickly and with minimal effort in the palm of your hand using Medhands patented technology.
Important: This is a downloaded, offline app. The application is a single edition only; to stay updated it is recommended to purchase the forthcoming editions as they are revised twice yearly.
Functions include:
• A powerful search• Bookmarks, History and Highlighting• Complete set of medical calculators; Body Mass Index, Peak Expiratory Flows, Dehydration Correction Calculator and more• Notes and picture notes
The September 2016 British National Formulary provides up-to-date, practical guidance on prescribing, dispensing, and administering medicines. This essential reference reflects current best practice as well as legal and professional guidelines relating to the uses of medicines.
BNF 72 has been revised and revalidated to reflect changes in product availability, emerging safety concerns and shifts in clinical practice. Access to the latest edition of the BNF is vital for healthcare professionals, as there are a large number of updates from one edition to the next.
Some of the significant content updates for the title include:
• New safety information about the risk of abnormal pregnancy outcomes with sodium valproate and valproic acid• Updated guidance for conditions including asthma, obesity, coeliac disease, irritable bowel syndrome and prostate cancer• New drug monographs including edoxaban, albiglutide, dulaglutide, dasabuvir, and vortioxetine• Updated pregnancy-prevention advice for patients taking mycophenolate mofetil• Updated guidance on the risk of hepatitis B reactivation with BCR-ABL tyrosine kinase inhibitors, and pomalidomide• Advice about the risk of ulceration with nicorandil treatment• NICE guidelines including the use of vedolizumab for treating moderately to severely active Crohn’s disease• New guidance on suspected or confirmed drug allergy• Evidence grading of BNF recommendations.
Improvements in the new edition
Since the launch of the new format we have actively sought your comments and feedback, and as a result have made the following improvements to this edition:
• Important safety information is displayed prominently within the monograph• Class monographs (e.g. ACE inhibitors) are easy to navigate to from the individual monographs.
The BNF evaluates clinical evidence from diverse sources with information validated by a network of clinical experts and published under the authority of a Joint Formulary Committee.
Authors: Joint Formulary Committee________________________________________
MedHand Mobile Libraries offers a SUBSCRIPTION FREE application without edition upgrade. Offering most trusted and well recognized medical guidelines provided by excellent publishers like Pharmaceutical Press, Oxford University Press, McGraw-Hill, Wiley, Elsevier and more.